Spironolactone Tablet, Film Coated
Product Images NDC 70771-1028

6 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70771-1028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (294f070b Bec7 4720 A615 C0fb4135191c 01)

Image (294f070b Bec7 4720 A615 C0fb4135191c 01)
Chemical structure of spironolactone, a steroidal compound with multiple ring structures and functional groups including a lactone and a thioester moiety.*
FDA Label Image

Image (294f070b Bec7 4720 A615 C0fb4135191c 02)

Image (294f070b Bec7 4720 A615 C0fb4135191c 02)
A Kaplan-Meier survival curve comparing the probability of an event over time in months between two groups: one receiving Spironolactone (n=822) and one receiving Placebo (n=841). The graph shows a higher survival probability in the Spironolactone group, with a statistically significant difference (Log-rank p < 0.001).*
FDA Label Image

Image (294f070b Bec7 4720 A615 C0fb4135191c 03)

Image (294f070b Bec7 4720 A615 C0fb4135191c 03)
A horizontal forest plot depicting hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone to placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACEI, and beta blocker use. The plot visually indicates the relative effect of spironolactone versus placebo across these categories.*
FDA Label Image

Image4 (294f070b Bec7 4720 A615 C0fb4135191c 04)

Image4 (294f070b Bec7 4720 A615 C0fb4135191c 04)
Label for spironolactone tablets, USP 25 mg, film-coated oral tablets. The label displays a white round tablet imprinted with '650' and indicates a package count of 100 tablets. The labeler is Zydus Lifesciences Limited, with manufacturing by Cadila Healthcare Ltd., Baddi, India. Storage and dosage instructions along with safety warnings are included.*
FDA Label Image

Image5 (294f070b Bec7 4720 A615 C0fb4135191c 05)

Image5 (294f070b Bec7 4720 A615 C0fb4135191c 05)
Label for Spironolactone Tablets USP, 50 mg film-coated oral tablets. The package contains 100 tablets. The label shows a single oval tablet imprinted with "651". Manufactured by Cadila Healthcare Ltd., Baddi, India, and distributed by Zydus Lifesciences Limited. Storage instructions and safety warnings are included.*
FDA Label Image

Image6 (294f070b Bec7 4720 A615 C0fb4135191c 06)

Image6 (294f070b Bec7 4720 A615 C0fb4135191c 06)
Label for Spironolactone Tablets, USP 100 mg oral film-coated tablets by Zydus Lifesciences Limited. The label shows white round tablets embossed with '562' and a score line. Packaging contains 100 tablets. Includes storage instructions, manufacturer information (Cadila Healthcare Ltd., Baddi, India), and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.